Ryosaku Inagaki

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino et al. · Nature · 2019 · 245 citations

Inflammation, Frequent Mutations, Autoimmune Disease +9

Tetraspanin CD151 Protects against Pulmonary Fibrosis by Maintaining Epithelial Integrity

Kazuyuki Tsujino, Yoshito Takeda, Toru Arai et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 45 citations · Full text

E-cadherin–downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines

Kanako Yuki, Yoko Yoshida, Ryosaku Inagaki et al. · Scientific Reports · 2014 · 25 citations · Full text

Inhibition of dopamine receptor <scp>D1</scp> signaling promotes human bile duct cancer progression via <scp>WNT</scp> signaling

Akitada Yogo, Toshihiko Masui, Shigeo Takaishi et al. · Cancer Science · 2022 · 13 citations · Full text

Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body

Yosuke Ota, Ryosaku Inagaki, Yosuke Takanashi et al. · ACS Nano · 2024 · 12 citations · Full text